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Intracellular virus stainingMouse adenovirus type 1 (MAV-1) causes acute and persistent infections in mice, with high levels of virus
found in the brain, spinal cord and spleen in acute infections. MAV-1 infects endothelial cells throughout the
mouse, and monocytes/macrophages have also been implicated as targets of the virus. Here we determined
the extent and functional importance of macrophage infection by MAV-1. Bone marrow-derived
macrophages expressed MAV-1 mRNAs and proteins upon ex vivo infection. Adherent peritoneal
macrophages from infected mice expressed viral mRNAs and produced infectious virus. Infected chemokine
(C–C motif) receptor 2 (CCR2) knockout mice, which are defective for macrophage recruitment, did not show
differences in survival or MAV-1 load compared to controls. In contrast, macrophage depletion using
clodronate-loaded liposomes resulted in increased virus replication in spleens of a MAV-1-resistant mouse
strain, BALB/cJ. Thus macrophages serve both as targets of infection and as effectors of the host response.
© 2009 Elsevier Inc. All rights reserved.IntroductionMouse adenovirus type 1 (MAV-1) causes a fatal disease in immu-
nocompetent newborn and adultmice at doses as low as 1–100 plaque
forming units (PFU) (Guida et al., 1995; Ishibashi and Yasue, 1984;
Kring et al., 1995). MAV-1 infection of immunodeﬁcient mice, like
human adenovirus infection of immunosuppressed patients, can
result in pneumonia, hepatitis, encephalitis, gastroenteritis, and
disseminated disease involving multiple organs (Carrigan, 1997;
Charles et al., 1998; Moore et al., 2003, 2004; Pirofski et al., 1991).
To understand how MAV-1 disseminates and causes disease in
immunocompetent and immunodeﬁcient mice, it is important to
know the cell types it infects and how infection affects their normal
cell function. MAV-1 targets endothelial cells throughout the mouse,
with the highest levels of virus being found in the brain, spinal cord,
and spleen (Charles et al., 1998; Guida et al., 1995; Kajon et al., 1998;
Kring et al., 1995;Moore et al., 2003). Cells of themonocyte lineage are
potentially targets of infection byMAV-1, but their infection byMAV-1
has not been well studied previously. MAV-1 early region 3 (E3)
nucleic acidwas detected by in situ hybridization in cells histologically
identiﬁed as macrophages (Kajon et al., 1998). MAV-1 E3 antigen was
reported to be detected in Kupffer cells of MAV-1-infected miceand Immunology, University of
3Medical Science Bldg. II, Ann
ll rights reserved.(Lenaerts et al., 2005). Macrophage cell lines can be productively
infected by MAV-1 in vitro (Spindler et al., unpublished).
Cells of the monocyte lineage are key effectors of the innate
immune response. Circulating monocytes differentiate into macro-
phages, and dendritic cells (DCs) are also derived from monocytes
(reviewed in Dale et al., 2008). There are three primary functions of
monocytic phagocytes: antigen presentation, phagocytosis of debris
and pathogens, and immunomodulation. Due to these functions,
monocytic phagocytes also are effector and regulatory cells of the
adaptive immune response.Whenmonocytic cells become infected by
viruses or bacteria, these innate and adaptive immune functions can
be compromised.
To determine whether MAV-1 replicates in primary macrophages
or whether it is simply phagocytosed by them, in this work we
examined ex vivo infection of bone marrow-derived macrophages.
We also isolated peritoneal macrophages and splenic macrophages
from MAV-1-infected mice and demonstrated that MAV-1 early and
late genes are expressed in both these cell types and infectious virus
is produced in peritoneal macrophages. Since macrophages are
effector cells of the innate response, and because they are a target of
MAV-1 infection, we investigated whether biochemical depletion of
macrophages compromised immune function and thus altered the
outcome of MAV-1 infection.We quantitated viral loads in brains and
spleens of mice of a MAV-1-resistant strain, BALB/cJ, whose
macrophages had been depleted with clodronate-loaded liposomes.
We also measured viral loads in brains and spleens of MAV-
1-infected BALB/cJ mice knocked out for CCR2. Our data indicate
that macrophages are both targets of MAV-1 and effectors of the
immune response to infection.
Fig. 2. Intracellular virus staining for MAV-1. (A–D) Bone marrow-derived macrophages
were mock-infected or infected with of MAV-1 (MOI=5) for 48 h. Cells were ﬁxed,
permeabilized and stained with antibody to F4/80 and either CD11b (A, C) or MAV-1 E3
gp11K (E3) (B, D). The number in each quadrant indicates the percentage of total cells
that are in that quadrant. In panel A, cells were permeabilized but only labeled with
secondary antibody, to control for autoﬂuorescence of the cells; C is a control showing
that the majority of cells stained with both macrophage markers.
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MAV-1 infects macrophages and CD11c+ cells
We previously showed that MAV-1-speciﬁc nucleic acid is
detectable by in situ hybridization in macrophages of outbred Swiss
mice (Kajon et al., 1998). To determine whether the virus replicates in
monocytes, we performed ex vivo infections of bone marrow-derived
macrophages and DCs.We cultured primarymouse bonemarrow cells
from 3-week old mice with either granulocyte-macrophage colony-
stimulating factor (GM-CSF/CSF2), which causes monocytes to
differentiate into DCs (Zou and Tam, 2002), or with L cell media
that provides macrophage colony-stimulating factor (M-CSF/CSF1)
for macrophage differentiation (Tushinski et al., 1982). After six days
of culture, an aliquot of the cells cultured to producemacrophages was
stained for ﬂow cytometry with antibodies to twomacrophage surface
markers, F4/80 and CD11b. The majority of cells present were positive
for both markers (N99%, data not shown). Cells from the GM-
CSF-treated cultures were incubated with magnetic beads coupled to
CD11c antibody to positively select immature DCs. The CD11c
selection routinely resulted in a population of cells that was N90%
CD11c+ (data not shown). Some natural killer (NK) cells have
also been shown to be CD11c+ (Laouar et al., 2005), so they may
have been present in the CD11c+ population from spleens; it is not
knownwhether NK cells are infected by MAV-1. The macrophages and
CD11c+ cells from both bone marrow and spleen were then mock-
infected or infected with MAV-1 at a multiplicity of infection (MOI)
of 5 for 48 h, and mRNA was isolated and analyzed by reverse
transcriptase-polymerase chain reaction (RT)-PCR with MAV-1 E3 or
mouse β-actin primers. We reasoned that if the virus were replicating
and not simply present subsequent to phagocytosis, viral mRNAwould
be detected. Fig. 1 shows the results for the bone marrow-derived
CD11c+ cells (lanes 2 and 3) and macrophages (lanes 5 and 6).
E3 mRNA was detected in all the infected samples, indicating that
MAV-1 infected both macrophages and CD11c+ cells from bone
marrow ex vivo.
We conﬁrmed the result that MAV-1 is transcriptionally active in
bone marrow-derived macrophages using intracellular virus staining
(ICVS). We modiﬁed a protocol of Weaver and Kadan (2000), used for
human adenoviruses. Bone marrow-derived macrophages were
isolated and infected or mock-infected as above, and then ﬁxed,
permeabilized, and stained with antibody to F4/80 and either CD11b
or MAV-1 E3 gp11K protein. Controls showed that the majority of cells
stained with both macrophage markers (Fig. 2C) and there was little
background staining (Fig. 2A). F4/80+ cells from infected mice were
speciﬁcally stained with the anti-E3 gp11K antibody (compare Fig. 2B
and D). This conﬁrms that macrophages were infected by MAV-1 and
indicates that an early protein was expressed.
Wenext examinedwhetherMAV-1 is replicating inmacrophages in
infected animals.We isolated peritoneal exudate cells (PECs) of SJL/JCr
mice infected intraperitoneally (i.p.) with 104 PFU of MAV-1 for 4 days
or from control mock-infected mice. The PECs were allowed to attach
for ∼3 h to tissue culture dishes; 1 h after plating, 90% of adherent cells
are macrophages (Davies and Gordon, 2005). RNA from the adherentFig. 1.Myeloid cells are infected by MAV-1 ex vivo. RT-PCR was performed with MAV-1
E3 primers or β-actin primers on mRNAs isolated 48 h post infection of cells ex vivo
with MAV-1 (MOI=5) or mock-infected. Lane 1, water (negative control); lanes 2 and
3, mock- and MAV-1-infected bone marrow-derived CD11c+ cells, respectively; lane 4,
MAV-1-infected 3T6 cells (positive control); lanes 5 and 6, mock and infected bone
marrow-derived macrophages, respectively. The data are representative of three
replicate experiments.cells was isolated and analyzed by RT-PCR with primers speciﬁc for
genes for MAV-1 E3, MAV-1 hexon (a late viral capsid protein), or
mouse β-actin. The results showed that the PECs from infected mice
expressed E3 (Fig. 3, lanes 4, 5) and hexon mRNA (lane 9). Similar
results were obtained at different times and virus doses in inbred and
in outbred Swiss mice (data not shown). Adherent cells isolated from
spleens of SJL/JCr infectedmicewere also positive forMAV-1 E3 (Fig. 3,
lane 13). To demonstrate that infection of these cells was productive,Fig. 3. MAV-1 is transcriptionally active in adherent peritoneal exudate cells and
splenocytes. SJL/JCr mice were mock-infected (M) or infected (V) with 104 PFU MAV-1
for 4 days, and RNA was isolated and analyzed by RT-PCR from peritoneal exudate cells
or splenocytes. Lanes 1–6, RNAs from adherent peritoneal exudate cells (macrophages)
were analyzed for MAV-1 E3 or mouse β-actin. Peritoneal exudate cell samples were
also ampliﬁed with primers for MAV-1 hexon; lanes 8–10were ampliﬁed from the same
RT products used in lanes 3, 5, and 6, respectively. Lanes 12 and 13, adherent cells from
the splenocyte population (macrophages) were obtained and RNAs were isolated and
analyzed for MAV-1 E3 and mouse β-actin. H2O and +, negative and positive PCR
controls, respectively. β-actin controls show that the RT products from mock-infected
cells were ampliﬁable by PCR. Data are representative of at least two independent
experiments for each sample type.
Fig. 4. Quantitation of virus in macrophages from infected mice. Adherent peritoneal
exudate cells isolated 4 days after infection of SJL/JCr mice with 104 PFU of MAV-1 were
assayed by TCID50 at 1, 48, or 96 post plating for the amount of virus produced. Each
value is from an independent experiment with intraperitoneal macrophages pooled
from 15 mice/experiment. The line connects the average of titers at each time point
(n=3 at 1 and 48 h; n=2 at 96 h).
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from infected SJL/JCr mice by 50% tissue culture infectious dose
(TCID50) assays at 1, 48, and 96 h after cells had adhered (Fig. 4). Virus
yields increased over time, indicating that adherent peritoneal cells
were productively infected in SJL/JCr mice by MAV-1. SJL mice are
highly susceptible toMAV-1, whereas BALB/cmice are less susceptible
(Spindler et al., 2001; Welton et al., 2005). In a similar TCID50 assay of
adherent peritoneal cells from BALB/c mice infected at the same dose
and time as the SJL/JCr mice (104 PFU, assayed 4 days post infection),
we detected no infectious virus (data not shown). However we found
similar levels of virus yield from bonemarrowmacrophages of BALB/c
and SJL/JCr mice infected ex vivo, 1.2×105 and 2.0×105 PFU/ml,
respectively. These data suggest that the strain differences in
susceptibility between SJL and BALB/c mice are manifested only inFig. 5. Clodronate liposome depletion of BALB/cJ and SJL/J mouse macrophages. Mice were t
infected with 102 PFU MAV-1 or mock-infected. (A) Brain viral loads from mice of the indica
viral loads of the same mice as in A. Some mice had such small spleens that after conﬁrmatio
Each bar represents the viral load of an individual mouse and each mouse homogenate wa
are shown. There were no statistically signiﬁcant differences between PBS and Lipo sam
(Mann–Whitney U test).vivo in assays of macrophages. The higher susceptibility of SJL mice
to MAV-1 infection may be a cause or effect of the higher replica-
tion levels in vivo seen in peritoneal cells of those mice compared to
BALB/c mice.
Effects of macrophage depletion on replication of MAV-1 in the brains
and spleens of BALB/cJ and SJL/J mice
Based on the results indicating that MAV-1 infects macrophages in
mice, we examined whether biochemical depletion of macrophages
would alter the outcome of pathogenesis in mice after infection. We
used clodronate-loaded liposomes, which deplete macrophages from
liver, spleen, lymph nodes, and peritoneum, but not brain or blood
monocytes (Van Rooijen,1989). We treated BALB/cJ or SJL/J micewith
i.p. injections of liposomes two days prior to i.p. infectionwith 102 PFU
of MAV-1; these inbred mice are resistant and susceptible to MAV-1
infection, respectively (Spindler et al., 2001; Welton et al., 2005).
Eight days post infection, mice were euthanized and organs were
harvested for analysis. We conﬁrmed the effectiveness of the
clodronate treatment by ﬂow cytometry with antibody to F4/80:
clodronate liposomes routinely depleted splenic macrophages to
5–15% of untreated levels (data not shown). The treatment in both
strains of mice did not alter clinical signs of infection (data not
shown). A few infected SJL/J mice showed neurological signs
(seizures) as they were transferred for euthanasia, but this was seen
in both control and clodronate liposome-treated mice. Control (PBS-
treated) MAV-1-infected BALB/cJ mice had low viral loads and SJL/J
mice had high viral loads (Fig. 5A), consistent with these strains being
resistant and susceptible to MAV-1, respectively (Spindler et al., 2001;
Welton et al., 2005). Viral loads were measured by capture ELISA
(Welton and Spindler, 2007). Treatment with clodronate liposomes
did not alter the brain viral loads for either strain relative to controls:
again levels were low in BALB/cJ mice and high in SJL/J mice (Fig. 5A).reated with 400 μl PBS or clodronate liposomes (Lipo) two days prior to infection, then
ted strains and treatments 8 days post infection, measured by capture ELISA. (B) Spleen
n of macrophage depletion, insufﬁcient samples remained for viral load determination.
s assayed in triplicate in the ELISA. The mean and standard deviation of the triplicates
ples for any group except for spleen viral loads in BALB/cJ mice, in which P=0.003
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statistically signiﬁcant difference between the mean brain viral loads
of control and clodronate-treated mice for either mouse strain. This
suggests that depletion of those populations of macrophages affected
by clodronate liposomes (e.g., peritoneal and splenic macrophages)
did not signiﬁcantly alter the infection as measured in the brain.
In contrast, when we examined spleens, we found that clodronate
liposome treatment did affect the infection in BALB/cJ mice (Fig. 5B).
The median spleen viral load (ELISA value) for BALB/cJ mice treated
with clodronate liposomes was 0.33 OD450 units, compared to 0.04
for controls. This difference was statistically signiﬁcant by Mann–
Whitney U test (P=0.004). SJL/J mice did not have altered spleen
viral loads upon clodronate liposome treatment; the high levels of
virus in spleens were consistent with previous results for infection of
this susceptible strain (Spindler et al., 2001). The results for BALB/cJ
spleens suggest that peritoneal and splenic macrophages are
protective against MAV-1 infection.
CCR2−/− mice are able to clear MAV-1 infection similar to controls
To address the importance of macrophage function in another way,
we determined whether mice genetically defective in macrophage
recruitment fared better or worse than control mice when infected
with MAV-1. We used CCR2−/− mice, which lack the receptor for the
chemokine CCL2 and other ligands (Kuziel et al., 1997). Thesemice are
defective for recruitment of macrophages to the peritoneum (Boring
et al., 1997; Kurihara et al., 1997; Kuziel et al., 1997), liver (Dambach
et al., 2002; Hokeness et al., 2005), central nervous system (Held et al.,
2004), and kidney (Kitagawa et al., 2004). Whether they are defective
for recruitment to the lung is dependent on the model (Baran et al.,
2007; Lu et al., 1998; Moore et al., 2001), and to our knowledge, effects
on other organs have not been reported. CCR2−/− mice on a BALB/cJ
strain background or wild-type BALB/cJ mice were infected i.p. with
102 or 106 PFU of MAV-1. Brains and spleens were harvested 8 days
post infection and assayed for viral loads (Fig. 6). No signiﬁcant
differences in brain viral loadswere seen between control BALB/cJ and
CCR2−/− mice at either virus dose, although there were slightly
higher virus levels in mice of both strains that received the 106 PFU
dose compared to the 102 PFU dose. Similarly, there were no
signiﬁcant differences between spleen viral loads in BALB/cJ vs.
CCR2−/− mice at either dose, though in both strains the mice that
received 106 PFU had higher viral loads. In addition, CCR2−/− mice
were given doses of 104, 105, or 106 PFU of MAV-1 and monitored for
21 days post infection. Morbidity and mortality due to MAV-1 infec-
tion usually occur within the ﬁrst 3–14 days post infection (reviewedFig. 6. Viral loads in brain and spleen after MAV-1 infection of CCR2−/−mice. BALB/cJ or CCR2
(A) and spleen (B) viral loads 8 days post infectionwere measured by capture ELISA. Each ba
in triplicate in the ELISA. The mean and standard deviation of the triplicates are shown.in Spindler et al., 2007). The mice survived to 21 days, exhibited no
clinical signs, and had no virus detectable by ELISA in brains and
spleens at the conclusion of the experiment (data not shown).
Together, these data suggest that the lack of CCR2 did not render
BALB/cJ mice more susceptible to MAV-1.
Discussion
Prior to this work there was evidence that MAV-1 proteins and
nucleic acid are found in cells of the monocyte lineage in infected mice
(Kajon et al.,1998; Lenaerts et al., 2005). Because themethods bywhich
the presence of the viruswas detected are onlymoderately sensitive, we
postulated that the virus is not simply phagocytosed, but that it
replicates in the cells to levels such that nucleic acid and antigen are
detectable. To test this, we used RT-PCR to detect expression of viral
mRNAs, which would not be present in non-replicating (phagocytosed-
only) virus particles. We ﬁrst demonstrated that MAV-1 infects macro-
phages and bonemarrow-derived CD11c+ cells (predominantly DCs) ex
vivo; both early and late viral gene expressionwas detectedwhen these
monocyte-derived cellswere isolated by standardmethods and infected
withMAV-1. The bonemarrow-derived CD11c+ cell populationwas not
100% pure (it was N90% CD11c+), and NK cells can also be CD11c+, so
further experiments will be needed to determine whether DCs are
infected ex vivo by MAV-1. The intracellular virus staining assay
provided strong corroboratingevidenceof theﬁnding thatmacrophages
are expressing early MAV-1 genes: F4/80+, CD11b+ cells were positive
for early protein expression by this assay.
We also examined whether MAV-1 infects macrophages in mice.
We found that adherent peritoneal and splenic cells from infected
mice expressed mRNA for MAV-1 E3, an early gene. It was possible
that viral genes were expressed but infectious virus was not produced,
so we also assayed for infectious virus. We were unable to detect virus
production from adherent peritoneal cells by plaque assays, which
have a limit of detection of 2×102 PFU/ml. Thus we turned to a more
sensitive assay and demonstrated that these cells did produce a low
level of infectious virus. This low level of virus production (1 TCID50
unit/300 peritoneal macrophages) suggests that replication is inef-
ﬁcient and/or that only a small subset of cells is capable of producing
mature virus. For comparison, we have determined virus yield from
permissive 3T6 ﬁbroblasts to be 90 PFU/cell (data not shown). A block
to efﬁcient virus production could occur at many steps subsequent to
early viral gene mRNA synthesis, including DNA replication, post-
transcriptional events (protein translation and stability), virus matu-
ration, and release. Since the adherent cell populations are enriched
(N90%) for macrophages, it is possible that a non-macrophage−/−micewere infectedwith 102 or 106 PFU of MAV-1 ormock-infected for 8 days. Brain
r represents viral load of an individual mouse and each mouse homogenate was assayed
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given the results of the intracellular virus staining of F4/80+, CD11b+
cells, we believe that macrophages are a target of MAV-1 infection and
that they produce infectious virus.
It is perhaps not surprising that MAV-1 is found in mouse macro-
phages, because human adenoviruses (hAds) are rapidly taken up and
cleared by alveolar macrophages when virus is administered to mice
via the pulmonary route (Zsengellér et al., 2000), and bymacrophages
of the liver, Kupffer cells, when given intravenously (Alemany et al.,
2000; Lieber et al.,1997; Tao et al., 2001;Wolff et al.,1997). This uptake
by Kupffer cells has been associated with rapid cell death when very
large doses of virus are given (Manickan et al., 2006). Uptake of hAds
by mouse Kupffer cells involves scavenger receptors rather than
integrins or the coxsackievirus and adenovirus receptor, and opsoniza-
tion by natural IgM antibodies and complement contribute to
clearance of the virus (Xu et al., 2008). To our knowledge there are
no reports of hAd infection of macrophages in people, but in vitro
studies indicate that the virus can bind and enter monocytic cells via
integrins (Huang et al., 1996).
Because macrophages are effectors of innate and adaptive
immunity, it seemed possible that depletion of macrophages might
increase the severity of MAV-1 infection. Alternatively, because
macrophages are targets of MAV-1 infection, their depletion might
decrease disease severity. Depletion of macrophages generally makes
animals more susceptible to pathogens, including fungi, parasites,
bacteria, and viruses (Pinto et al., 1991; Qian et al., 1994; Vreden et al.,
1993). We investigated the effect of depleting mice of liver, spleen,
lymph node and peritoneal macrophages by treatment with clodro-
nate-loaded liposomes (Van Rooijen, 1989). This treatment does not
deplete brain or blood monocytes, though in the spleen it has been
shown to deplete marginal DCs of the spleen (Leenen et al., 1998). We
used a resistant mouse strain, BALB/cJ, to determine whether the
treatment would increase pathogenesis (by removing immune effec-
tor cells), and a susceptible mouse strain, SJL/J, to determine if the
treatment would decrease pathogenesis (by removing target cells)
(Spindler et al., 2001; Welton et al., 2005). Viral loads in susceptible
SJL/J mice were unchanged by treatment with the liposomes. In
contrast, viral loads in the spleens of BALB/cJ mice were signiﬁcantly
higher in macrophage-depleted mice, approaching levels seen in
spleens of susceptible SJL/J mice. Thus depletion of macrophages
increased the severity of infection in resistant mice, as measured by
spleen viral loads. The BALB/cJ brain viral loads did not differ between
control- and liposome-treated mice. This could be due to the fact that
brain macrophages are not depleted by the clodronate liposome
treatment. This result could also occur if macrophages do not play a
role in controlling viral levels in the brain. The experiments described
here do not distinguish between these possibilities, which are not
mutually exclusive. However, we have observed that MAV-1 infection
does result in increased numbers of macrophages in brains of C57BL/
6NCr mice (Gralinski and Spindler, unpublished). Expression of F4/80
mRNA is increased in MAV-1-infected mouse brains relative to mock-
infected mice (Weinberg et al., 2007). These results suggest that there
may be a protective role for macrophages in the brain. If macrophages
contribute to dissemination of the virus from peritoneum to the brain,
then there must also be a second mechanism for dissemination since
macrophage depletion did not affect brain viral loads. Treatment of
mice intraperitoneally by clodronate liposomes resulted in depletion
of 85–95% of splenic macrophages; these numbers are comparable to
results obtained by others (van Rooijen et al., 1989). Our data suggest
that the residual macrophages were not able to protect BALB/cJ mice
from viral replication in the spleen.
In other models that examine the role of macrophages in viral
infection, depletion of macrophages by clodronate liposome treat-
ment or other means also results in increased viral replication in the
spleen or other organs. For example, in hAd infection of rats, when
infection of Kupffer cells is blocked by treatment with polyinosinicacid, there is an increase in infection of surrounding liver cells
(Haisma et al., 2008). Clodronate liposome treatment of mice
increases replication of mouse cytomegalovirus in the spleen (Hanson
et al., 1999). In addressing whether macrophages function more as
targets or effectors in mouse cytomegalovirus infection, the authors
concluded that the latter role, particularly the production of cytokines,
outweighs the role of macrophages as target cells. Their data suggest
that the macrophages may function as “ﬁlters” or “sinks” for the virus,
keeping other permissive cell types from being infected by the virus. A
somewhat analogous result was found for measles virus, for which
macrophages are a major target (Roscic-Mrkic et al., 2001). Mice are
not a natural host for measles, but in transgenic mice expressing the
measles receptor, human CD46, the most efﬁciently infected periph-
eral blood mononuclear cells are F4/80+ (macrophages). Depletion of
splenic or lung macrophages in these mice resulted in enhanced viral
replication in the spleen or lung, respectively. Furthermore, in each
organ, there was a concomitant activation and infection of DCs. Thus
macrophages contribute to protection of other immune cells from
measles infection. We do not know whether macrophages similarly
protect other immune cells, such as endothelial cells or DCs, from
MAV-1 infection, or whether macrophages protect other surrounding
cell types from MAV-1 infection, similar to the protective effect
postulated for Kupffer cells in hAd infection (Haisma et al., 2008).
In our macrophage depletion experiments we assayed mice eight
days after MAV-1 infection, and thus it is possible that the resulting
increased viral load in BALB/cJ spleens was due to lack of both innate
and adaptive functions of macrophages. For many cases where virus
infection has been examined in the context of macrophage depletion,
an early/innate role for macrophages in control of the infection has
been deduced (Ben-Nathan et al., 1996; Pribul et al., 2008; Rivera et al.,
2007; Seiler et al., 1997; Zisman et al., 1970, 1971). However,
macrophage depletion also appears to affect the adaptive immune
response to some viruses, including ectromelia virus, mouse hepatitis
virus A59, and hAd vectors examined in mice (Karupiah et al., 1996;
Kuzmin et al., 1997, 2001; Lieber et al., 1997; Shifrin et al., 2005;
Wijburg et al., 1997).
In contrast to increased viral loads in the spleens of BALB/cJ mice
following macrophage depletion, we saw no differences in spleen or
brain viral loads of CCR2−/− mice infected with MAV-1 compared to
BALB/cJ mice. Thus clodronate liposome-depleted mice are not func-
tionally equivalent to mice that lack CCR2 with respect to MAV-1
infection. This may be due to differences in immune cell populations in
the two models, e.g., DCs. In addition to depleting macrophages,
clodronate liposome treatment depletes marginal DCs in the spleen but
not CD8+ interdigitating DCs (Leenen et al., 1998). A subset of CCR2+
murine blood monocytes recruited to inﬂammatory sites can diffe-
rentiate into DCs (Geissmann et al., 2003); this population would be
absent in the CCR2−/− mice. CCR2−/− mice are defective for
recruitment of macrophages to the peritoneum after a stimulus, but
the resident numbers of macrophages in the peritoneum do not differ
compared to wild-type mice (Boring et al., 1997; Kurihara et al., 1997;
Kuziel et al., 1997). We suggest that the resident macrophages or other
factors (e.g., cells or cytokines) in CCR2−/− mice were sufﬁcient to
protectmice fromMAV-1 replication in the spleen upon i.p. infection. In
most infection models using CCR2−/− mice there are increases in
replication of the infectious agent compared to control mice, for
example, infection with Toxoplasma gondii, Cryptococcus neoformans,
Listeria monocytogenes, Aspergillus fumigatus, mouse cytomegalovirus,
and neurotropic mouse hepatitis virus (Benevides et al., 2008; Blease et
al., 2000; Chen et al., 2001; Dunay et al., 2008; Held et al., 2004;
Hokeness et al., 2005; Kurihara et al., 1997; Traynor et al., 2000).
However, in the case of inﬂuenzavirus, infection of at least oneCCR2−/−
mouse strain showed no increases in inﬂuenza virus titers or delayed
viral clearance, though there were clear changes in leukocyte recruit-
ment compared to controls (Wareing et al., 2007). These authors
suggested that the deﬁciency in CCR2 may have altered the develop-
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virus infection. Scott and Flynn (2002) found that for Mycobacterium
tuberculosis infection, the dose affected whether differences were seen
between CCR2−/−mice and controls. At low doses, the CCR2-deﬁcient
mice had bacterial loads similar to wild-type mice and successfully
formed granulomas, whereas at high doses the mice were less able to
control infection thanwild-typemice. The authors suggest that the nor-
mal immune responsemaybegreater than is necessary for control of the
infection, such that deﬁciency in CCR2−/− does not have effects at low
doses of bacteria. Our results forMAV-1may havemore similarity to the
inﬂuenza case, because we found no difference in survival of CCR2−/−
mice compared to wild-type mice even at very high doses that resulted
in high viral loads in both mouse strains.
The highest levels of MAV-1 in infected mice are found in the brain
and spleen (Charles et al., 1998; Guida et al., 1995; Kajon et al., 1998;
Kring et al., 1995; Moore et al., 2003). MAV-1 causes encephalitis and
breakdown of the blood–brain barrier (Gralinski and Spindler, un-
published; Guida et al., 1995; Kring et al., 1995). The ﬁnding that
peritoneal macrophages produce infectious virus suggests that these
cells may play a role in dissemination of the virus to the brain and
spleen after i.p. inoculation, contributing to the pathogenesis of the
virus. It will be important to determine how macrophages function in
this regard and whether other monocytic cell types (e.g., DCs) are
similarly productively infected and contribute to dissemination.
Materials and methods
Mice, virus, and infections
All animal work complied with relevant federal and institutional
policies. All mice were maintained in microisolator housing with food
and water provided ad libitum. Outbred Swiss mice were obtained
from Harlan Laboratories. BALB/cJ and SJL/J mice were obtained from
The Jackson Laboratory; SJL/JCr mice were obtained from Charles
River Laboratories (NCI Animal Production Program). CCR2−/− mice
were a kind gift of Beth Moore. These mice (Ccr2tm1Mae) were
originally described by Kuziel et al. (1997) and were subsequently
crossed for 8 generations to the BALB/c background. Mice were
infected i.p. with the indicated dose of MAV-1 in 100 μl PBS or mock-
infected with conditioned media similarly diluted. Mice were
euthanized by CO2 asphyxiation, and their organs were harvested.
MAV-1was grown and titrated in NIH 3T6 cells, a mouse ﬁbroblast cell
line (Cauthen et al., 2007).
Isolation of adherent peritoneal exudate cells
Mice were euthanized and an excision was made to expose the
peritoneum. Five ml of sterile PBS was injected into the peritoneal
cavity using a 25 gauge needle, the abdomenwas gently palpated and
then the ﬂuid containing peritoneal cells was removed. The cells were
centrifuged 5 min at 300 ×g, red blood cells lysed in lysis buffer
(0.144 M NH4Cl, 0.017 M Tris, pH 7.2) for 2 min at room temperature,
then centrifuged 5 min at 300 ×g, washed twice in PBS, and
resuspended in Dulbecco's modiﬁed Eagle's medium (DMEM). Cells
were then counted, and 2×106 cells were plated in 10 ml DMEM
containing 10% heat-inactivated calf serum in a 10-cm tissue culture
plate, incubated for 3 h at 37 °C and non-adherent cells were removed.
Isolation of bone marrow-derived cells and splenocytes
Bone marrow was harvested by ﬂushing femurs of 3-week old mice
with 10mlDMEMusing a 26 gauge needle. Cellswere centrifuged 3min
at 460 ×g and resuspended in DMEM. For macrophage isolation, 5×106
cells were plated in 10mlmacrophagemedium (DMEM containing 20%
fetal bovine serum, 30% L929-conditioned media as a source of colony-
stimulating factor-1 (Tushinski et al., 1982), 2 mM glutamine, 100 U/mlpenicillin, 100 μg/ml streptomycin, and 55 μM 2-mercaptoethanol) in a
10-cm non-tissue culture treated Petri plate. L929-conditioned media
was prepared by growing L929 cells for 5 days or until cells were
conﬂuent in DMEMwith 10% fetal bovine serum, harvesting the media,
ﬁltering it through a 0.2 μm ﬁlter, and storing at−20 °C until use. Cells
were incubated at 37 °C and fed on day 3 by adding10 ml macrophage
media to the existing media and harvested on day 6.
For DC isolation, bonemarrow cells were resuspended in DCmedia
(DMEM containing 10% fetal bovine serum and 10 ng/ml GM-CSF [R
and D, Minneapolis MN]) at 5×105 cells/ml. One ml was plated per
well in 24-well plates, with incubation at 37 °C. On days 2 and 4, 1 ml
of DC media was added to the existing media. Cells were harvested on
day 6. Cells were incubated for 15 min at 4 °C with CD11c microbeads
that were prepared by adding 100 μl of CD11c microbeads (Miltenyi
Biotec, Auburn CA) per 108 cells. Cells were then centrifuged 10 min at
200 ×g, resuspended in wash buffer (PBS plus 0.5% bovine serum
albumin), centrifuged, resuspended in wash buffer, and passed
through a MACS column (Miltenyi Biotec, Auburn CA).
RNA isolation and RT-PCR
Total RNA was extracted with TRI Reagent (Molecular Research
Center, Inc., Cincinnati, OH) following the manufacturer's instructions.
Five μg of total RNA was reverse transcribed using random hexamer
primers and Moloney murine leukemia virus reverse transcriptase
(Invitrogen, San Diego, CA). Four μl of a 20 μl reverse transcriptase
reaction was then ampliﬁed in a reaction volume of 20 μl, using GoTaq
enzyme and buffer (Promega, Madison,WI) with denaturation 3min at
94 °C; 35 cycles of 30 s at 94 °C, 45 s annealing at 55 °C, 30 s extension at
72 °C; then a single 7min extension at 72 °C. Primers forMAV-1 E3were
MAVR24718 and MAVR25148 (Spindler et al., 2001); hexon primers
were HexFo2 (5′CACACCTTTCAGCGAGTTTCA3′) and HexRev2 (5′
GCCGGGCCAGGGGTTCAA3′) (Weinberg et al., 2007); mouse actin
primers were BetaActinUp (5′TGGAATCCTGTGGCATCCATGAAAC3′)
and BetaActinDown (5′TAAAACGCAGCTCAGTAACAGTCCG3′). E3 and
actin primers were designed to amplify across an intron sequence and
thus enable analysis speciﬁcally of cDNA. Samples analyzed for hexon
mRNAwere treated with Superasin DNAse (Ambion, Austin, TX) during
the reverse transciptase reaction. PCR products were analyzed on 7%
acrylamide gels electrophoresed 2 h at 200 V.
Macrophage depletion
Cl2MDP (clodronate) was a gift of Roche Diagnostics GmbH,
Mannheim, Germany. Multilamellar liposomes containing Cl2MDP
were prepared as described (Van Rooijen and Sanders, 1994). Each
mouse was given either 400 μl of PBS or clodronate liposomes i.p. two
days prior to infection. One hundred PFU of virus diluted in PBS or
conditioned media (removed from conﬂuent NIH3T6 cell monolayers
3–4 days after plating) similarly diluted was given i.p. in a 100 μl
inoculum.
Flow cytometric analysis for conﬁrmation of depletion
BALB/cJ and SJL/J splenocytes (7×106)were stainedwith antibodies
to F4/80 (Caltag, Burlingame, CA). Stained sampleswere analyzed using
a FACScan™ ﬂow cytometer and CellQuest™ software (BD Biosciences,
San Jose, CA) or FACSCanto™ ﬂow cytometer (BD Biosciences, San Jose,
CA) and FlowJo software (Ashland, OR). Efﬁcientmacrophage depletion
was conﬁrmed by quantitating F4/80+ cells and comparing their
numbers in clodronate liposome-treated and -untreated (PBS) samples.
Quantitation of virus
Viral loads from infected mice were quantitated by capture ELISA
as previously described (Welton et al., 2005; Welton and Spindler,
313S.L. Ashley et al. / Virology 390 (2009) 307–3142007). Previous experiments have shown that this method of
quantitation has a high correlation with virus quantitation by plaque
assay (Welton et al., 2005). An undiluted virus stock control
(3.85×107 PFU/ml) was included to ascertain the upper limit of
detection and to standardize assays performed at different times.
Yield of virus from adherent macrophages from peritoneal exudates
of infected mice was quantitated by a 50% tissue culture infectious dose
(TCID50) assay. Adherent cells (6×106) pooled from 15 SJL/JCr mice
4 days after infectionwith 104 PFU of MAV-1 i.p. were sampled at 1, 48,
and 96 h post plating. The cells were harvested in 5ml ofmedia, freeze–
thawed three times, and centrifuged to remove debris. Serial 10-fold
dilutions of the supernatants were plated (three or more wells per
dilution) on 2×104 cells/well of mouse 3T6 cells in 96-well plates.
Cytopathic effect was scored 4–6 days after infection. The TCID50 was
calculated as the inverse of the dilution at which 50% of the wells
showed cytopathic effect, calculated by themethod of Reed andMuench
(1938). A control virus stock of high titer was titrated by TCID50 and
plaque assay, and 1 PFU corresponded to 68 TCID50 units.
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